Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Hoffmann Reflex.

NeuroSci·2026
Same author

Restless Legs Syndrome: A Network Model of Iron-Dependent Neuromodulation-A Narrative Review.

Brain sciences·2026
Same author

Regulatory Variation at TERT and TERC Shows Limited Association with Early-Onset Alzheimer's Disease in Carriers of the Mexican Founder Mutation <i>PSEN1</i> A431E.

Medical sciences (Basel, Switzerland)·2026
Same author

Quantum-Inspired and Non-Classical Approaches to Consciousness: Models, Evidence and Constraints.

Brain sciences·2026
Same author

Combination therapy with pregabalin and thioctic acid offers safer pain control in diabetic neuropathy: a multicenter, double-blind, non-inferiority trial.

Brain communications·2026
Same author

L-Alliin Modulates Brain Region-Specific Neuroinflammatory Responses to Lipopolysaccharide in Diet-Induced Obese Mice.

Brain sciences·2026

Related Experiment Video

Updated: Jun 27, 2026

Non-invasive Assessment of Changes in Corticomotoneuronal Transmission in Humans
09:30

Non-invasive Assessment of Changes in Corticomotoneuronal Transmission in Humans

Published on: May 24, 2017

8.3K

Optimizing Hoffmann Reflex Rate-Dependent Depression: A Feasible Protocol for Assessing Spinal Inhibition in Upper

Andrea S Ceñal Cisneros1, Rodolfo Delgado-Lezama2, Carlos A Cuellar3

  • 1Departamento de Fisiologia, Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City 04360, Mexico.

Medical Sciences (Basel, Switzerland)
|February 20, 2026
PubMed
Summary

Standardized assessment of rate-dependent depression of the Hoffmann reflex (RDD-HR) in upper and lower limbs is now feasible. A simplified protocol using a single seven-pulse train at specific frequencies provides reliable spinal inhibition measures.

Keywords:
Hoffmann reflexbiomarker standardizationelectrophysiologyneuropathic painrate-dependent depressionspinal disinhibition

More Related Videos

Terminal H-reflex Measurements in Mice
05:38

Terminal H-reflex Measurements in Mice

Published on: June 16, 2022

6.5K
The Evoked Potential Operant Conditioning System EPOCS: A Research Tool and an Emerging Therapy for Chronic Neuromuscular Disorders
10:08

The Evoked Potential Operant Conditioning System EPOCS: A Research Tool and an Emerging Therapy for Chronic Neuromuscular Disorders

Published on: August 25, 2022

3.4K

Related Experiment Videos

Last Updated: Jun 27, 2026

Non-invasive Assessment of Changes in Corticomotoneuronal Transmission in Humans
09:30

Non-invasive Assessment of Changes in Corticomotoneuronal Transmission in Humans

Published on: May 24, 2017

8.3K
Terminal H-reflex Measurements in Mice
05:38

Terminal H-reflex Measurements in Mice

Published on: June 16, 2022

6.5K
The Evoked Potential Operant Conditioning System EPOCS: A Research Tool and an Emerging Therapy for Chronic Neuromuscular Disorders
10:08

The Evoked Potential Operant Conditioning System EPOCS: A Research Tool and an Emerging Therapy for Chronic Neuromuscular Disorders

Published on: August 25, 2022

3.4K

Area of Science:

  • Neurophysiology
  • Spinal Cord Research
  • Biomarker Development

Background:

  • Rate-dependent depression of the Hoffmann reflex (RDD-HR) is a marker of spinal inhibition.
  • Current RDD-HR assessment lacks standardized parameters for frequency, stimuli number, and limb applicability.
  • Neurological conditions can alter RDD-HR, highlighting the need for reliable clinical assessment.

Purpose of the Study:

  • To establish standardized parameters for RDD-HR assessment in both upper and lower limbs of healthy adults.
  • To determine optimal stimulation frequency and minimal number of stimuli for reliable RDD-HR measurement.
  • To provide a foundation for RDD-HR's clinical application as a biomarker.

Main Methods:

  • Observational study recording bilateral Hoffmann reflexes from flexor carpi radialis and soleus muscles in 21 healthy adults.
  • Stimulation involved three 10-pulse trains across seven frequencies (0.1-5 Hz).
  • RDD-HR quantified by median H-reflex area relative to the first response; optimal parameters identified via sigmoid fitting and ANOVA.

Main Results:

  • RDD-HR showed a sigmoidal frequency-response across all limbs, with maximal depression at 1-5 Hz (1 Hz optimal).
  • Greater depression observed in lower limbs (~47%) compared to upper limbs (~30%).
  • A single seven-pulse train yielded reliable estimates, with no added benefit from averaging trains; upper limb recordings needed lower intensities.

Conclusions:

  • A simplified RDD-HR protocol using a single seven-pulse train at key frequencies enables reliable assessment.
  • This standardized approach supports future clinical validation of RDD-HR as a biomarker for spinal inhibitory dysfunction.
  • The findings pave the way for RDD-HR's use in diagnosing and monitoring neurological conditions affecting spinal inhibition.